Related references
Note: Only part of the references are listed.Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial
Lennie P. G. Derde et al.
LANCET INFECTIOUS DISEASES (2014)
Distinguishing Community-Associated From Hospital-Associated Clostridium difficile Infections in Children: Implications for Public Health Surveillance
Sarah Tschudin-Sutter et al.
CLINICAL INFECTIOUS DISEASES (2013)
An Environmental Disinfection Odyssey: Evaluation of Sequential Interventions to Improve Disinfection of Clostridium difficile Isolation Rooms
Brett Sitzlar et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2013)
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
Els van Nood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients
Cassandra D. Salgado
AMERICAN JOURNAL OF INFECTION CONTROL (2008)
Emergence and acquisition of fluoroquinolone-resistant gram-negative bacilli in the intestinal tracts of mice treated with fluoroquinolone antimicrobial agents
Michael J. Pultz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals
Deborah S. Yokoe et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Orally administered β-lactamase enzymes represent a novel strategy to prevent colonization by Clostridium difficile
Usha Stiefel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Colonic delivery of β-lactarnases does not affect amoxicillin pharmacokinetics in rats
Sandrine Bourgeois et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Bacteroides: the good, the bad, and the nitty-gritty
Hannah M. Wexler
CLINICAL MICROBIOLOGY REVIEWS (2007)
Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic Clostridium difficile strains in the Cecal contents of mice
Daniel A. Adams et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The challenges posed by reemerging Clostridium difficile infection
David B. Blossom et al.
CLINICAL INFECTIOUS DISEASES (2007)
National survey on the susceptibility of Bacteroides fragilis group:: Report and analysis of trends in the united states from 1997 to 2004
D. R. Snydman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship
Timothy H. Dellit et al.
CLINICAL INFECTIOUS DISEASES (2007)
EFfect of carbapenem administration on establishment of intestinal colonization by vancomycin-resistant enterococci and Klebsiella pneumoniae in mice
Usha Stiefel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Suppression of gastric acid production by proton pump inhibitor treatment facilitates colonization of the large intestine by vancomycin-resistant Enterococcus spp. and Klebsiella pneumoniae in clindamycin-treated mice
Usha Stiefel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Colonization and infection with vancomycin-resistant enterococcus among patients with cancer
Madonna J. Matar et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2006)
An epidemic, toxin gene-variant strain of Clostridium difficile
LC McDonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Orally administered recombinant metallo-β-lactamase preserves colonization resistance of piperacillin-tazobactam-treated mice
U Stiefel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Effects of daptomycin, linezolid, and vancomycin on establishment of intestinal colonization with vancomvcin-resistant enterococci and extended- spectrum-β-lactamase-producing Klebsiella pneumoniae in mice
NJ Pultz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Effect of antibiotic treatment on growth of and toxin production by Clostridium difficile in the cecal contents of mice
NJ Pultz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Mechanisms by which anaerobic microbiota inhibit the establishment in mice of intestinal colonization by vancomycin-resistant Enterococcus
NJ Pultz et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Effect of parenteral antibiotic administration on establishment of intestinal colonization by Candida glabrata in adult mice
NJ Pultz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Increased susceptibility to vancomycin-resistant Enterococcus intestinal colonization persists after completion of anti-anaerobic antibiotic treatment in mice
U Stiefel et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2004)
Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection
TS Naimi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Oral administration of β-lactamase preserves colonization resistance of piperacillin-treated mice
U Stiefel et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Coexistence of vancomycin-resistant enterococci and Staphylococcus aureus in the intestinal tracts of hospitalized patients
AJ Ray et al.
CLINICAL INFECTIOUS DISEASES (2003)
Antianaerobic antibiotic therapy promotes overgrowth of antibiotic-resistant, gram-negative bacilli and vancomycin-resistant enterococci in the stool of colonized patients
A Bhalla et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2003)
Colonization and infection with multiple nosocomial pathogens among patients colonized with vancomycin-resistant Enterococcus
CJ Donskey et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2003)
Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection
JJ Engemann et al.
CLINICAL INFECTIOUS DISEASES (2003)
Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S-aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia
M Melzer et al.
CLINICAL INFECTIOUS DISEASES (2003)
Impact of infection by vancomycin-resistant Enterococcus on survival and resource utilization for patients with leukemia
PB Bach et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2002)
Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes
RK Pelz et al.
INTENSIVE CARE MEDICINE (2002)
Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting
MA Montecalvo et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2001)
Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.
CJ Donskey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia
SM Bhavnani et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2000)
Share Paper
